Cantargia AB
F:7V3
Cantargia AB
F:7V3
Price:
0.1306
EUR
-27.44%
Market Closed
Market Cap:
€24m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cantargia AB
F:7V3
|
SE |
|
D
|
Dynagreen Environmental Protection Group Co Ltd
F:DYN
|
CN |
|
Alligator Bioscience AB
F:7AL
|
SE |
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
Largo Inc
F:LR8
|
CA |
|
S
|
Surteco Group SE
DUS:SUR
|
DE |
|
AVITA Medical Inc
F:51KA
|
US |
|
Papoutsanis Industrial and Commercial of Consumer Goods SA
F:Y2O
|
GR |
Wall St Price Targets
7V3 Price Targets Summary
Cantargia AB
Cantargia AB
Wall Street analysts forecast 7V3 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 7V3 is 0.8795 EUR with a low forecast of 0.5226 EUR and a high forecast of 1.5211 EUR.
Lowest Forecast
Price Target
0.5226
EUR
300% Upside
Average Forecast
Price Target
0.8795
EUR
573% Upside
Highest Forecast
Price Target
1.5211
EUR
1 065% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7V3's stock price target?
Price Target
0.8795
EUR
0.8795
EUR
According to Wall Street analysts, the average 1-year price target for 7V3 is 0.8795 EUR with a low forecast of 0.5226 EUR and a high forecast of 1.5211 EUR.
What is the Revenue forecast for Cantargia AB?
Projected CAGR
-38%
-38%
The compound annual growth rate for Revenue over the next 3 years is -38%.
